Investor Relations

Document Details

Document Details

Filing Type

8-K (SEC's EDGAR System)

Company Evolent Health, Inc. (Arlington, VA)
Event Date 10/17/2018
Filing Date 10/18/2018

Abstract: On Oct. 17, registrant announced the pricing of $150.0 million aggregate principal amount of 1.50% convertible senior notes due 2025.

File Section(s)

  1. 8-K
  2. EXHIBIT 99.1

Note: This document was filed with the SEC in HTML format, as allowed by the recent EDGAR system modernization. S&P cannot take responsibility for its appearance, layout, or legibility.